Literature DB >> 636889

Morphometric and dynamic studies of bone changes in hypothyroidism.

L Mosekilde, F Melsen.   

Abstract

Bone biopsies were performed after tetracycline double-labelling by transfixing the right iliac crest in fourteen hypothyroid patients. The bone changes in cortical and trabecular bone were determined by simple measurement and point counting on decalcified and undecalcified stained sections and compared to normal controls and to sex and age matched hyperthyroid patients. The amount of trabecular bone and the cortical porosity were unchanged in the hypothyroid patients compared to normal controls, whereas the mean cortical thickness was increased. The amount of osteoid and the length of the osteoid seams were normal, whereas the mean width of the osteoid seams was decreased. The linear calcification rate in cancellous bone was decreased, as were the active calcification surfaces (tetracycline-labelled) and the percentage of osteoid covered surfaces active in mineralization. The osteoclastic resorption surfaces were unchanged in trabecular bone, whereas the osteoclastic activity in cortical bone was decreased. The osteocytic osteolysis was normal. The bone changes in hypothyroidism were opposite to the changes in hyperthyroidism characterized by a very low bone turn-over with a reduced osteoid apposition and bone mineralization rate, an inactive osteoclastic resorption in trabecular bone and a decreased osteoclastic resorption in cortical bone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 636889     DOI: 10.1111/j.1699-0463.1978.tb02012.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  15 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

2.  Restoration of euthyroidism in women with Hashimoto's thyroiditis changes bone microarchitecture but not estimated bone strength.

Authors:  Maria Lohman Obling; Pia Nicolaisen; Thomas Heiberg Brix; Kristian Hillert Winther; Stinus Hansen; Laszlo Hegedüs; Anne Pernille Hermann; Steen Joop Bonnema
Journal:  Endocrine       Date:  2020-07-04       Impact factor: 3.633

3.  Risks Associated with Treating Hypothyroidism: Potential hazards of L-thyroxine therapy.

Authors:  H C Gerstein
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

4.  Biomechanical performance of diaphyseal shafts and bone tissue of femurs from hypothyroid rats.

Authors:  María I Conti; María P Martínez; María I Olivera; Clarisa Bozzini; Patricia Mandalunis; Carlos E Bozzini; Rosa M Alippi
Journal:  Endocrine       Date:  2009-08-11       Impact factor: 3.633

5.  A meta-analysis of studies investigating the effects of occupational lead exposure on thyroid hormones.

Authors:  Edward F Krieg
Journal:  Am J Ind Med       Date:  2016-04-20       Impact factor: 2.214

6.  Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.

Authors:  P Charles; J W Poser; L Mosekilde; F T Jensen
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

7.  Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study.

Authors:  Margaret C Garin; Alice M Arnold; Jennifer S Lee; John Robbins; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

Review 8.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

9.  Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.

Authors:  Alap L Christy; Vivian D'Souza; Ruby P Babu; Sohil Takodara; Poornima Manjrekar; Anupama Hegde; M S Rukmini
Journal:  Biomark Insights       Date:  2014-03-03

10.  Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT.

Authors:  Emil Moser; Tanja Sikjaer; Leif Mosekilde; Lars Rejnmark
Journal:  J Thyroid Res       Date:  2015-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.